Finding and joining a medical trial is more straightforward than most people expect. Over 64,000 studies are actively recruiting participants right now, about 22,000 of them in the United States. The process generally involves searching a trial database, confirming you meet the eligibility requirements, and going through a screening visit before enrollment. Here’s how each step works.
Search Trial Databases
The most comprehensive starting point is ClinicalTrials.gov, the federal registry that lists nearly 574,000 studies across 225 countries and territories. You can filter by condition, location, age, and recruitment status. For cancer specifically, the National Cancer Institute runs its own search tool at cancer.gov, where you can enter your cancer type, age, and ZIP code to find trials nearby or across the country.
Beyond the government databases, private platforms like CenterWatch list over 40,000 clinical research opportunities updated daily. These sites sometimes make it easier to browse by condition or treatment type. Your doctor or specialist can also refer you directly to trials at academic medical centers or hospital networks, which is especially useful if you have a complex diagnosis and want help narrowing options.
Understand What Each Phase Involves
Not all trials are the same. The phase tells you how far along a treatment is in development, and that directly affects your experience as a participant.
- Phase I: A small group of 20 to 80 people tests a new drug or treatment for the first time. The goal is to evaluate safety and identify side effects, not to treat a condition.
- Phase II: The group expands to 100 to 300 people. Researchers are now looking at whether the treatment actually works while continuing to monitor safety.
- Phase III: Large groups of 1,000 to 3,000 people participate. The treatment is compared against standard care or similar treatments, and the data collected here is what supports a request for FDA approval.
- Phase IV: These happen after a drug is already approved and available. Researchers track long-term safety and look for benefits or risks that only show up in larger, more diverse populations.
Phase I trials carry the most uncertainty because less is known about how the treatment behaves in humans. Phase III and IV trials involve treatments with more established safety profiles. Knowing the phase helps you weigh the potential risks against potential benefits before you apply.
Check Eligibility Criteria
Every trial publishes inclusion and exclusion criteria that determine who can participate. These are listed on the trial’s database page, so you can review them before contacting anyone. Common inclusion criteria include age range, a specific diagnosis, disease stage or stability, and sometimes geographic location. A lung disease trial, for example, might require participants to be at least 40 years old, have a confirmed diagnosis for at least a year, and be current or former smokers.
Exclusion criteria filter out people whose participation could be risky or could skew results. You might be excluded if you have certain other medical conditions, take medications that interact with the study treatment, or have a history of a related illness. These aren’t personal rejections. They exist to protect participants and ensure the data is reliable. If one trial excludes you, another studying the same condition may have different criteria.
Contact the Research Team
Once you find a trial that fits, reach out to the listed contact, typically a study coordinator or principal investigator. Their contact information appears on the trial listing. You can also ask your own doctor to make the referral, which sometimes speeds up the process.
The research team will usually do a brief phone screening first, asking about your medical history and current health to see if you’re a likely match. If that goes well, they’ll schedule an in-person screening visit that may include blood work, imaging, or other tests depending on the study. This visit is free to you. Some trials complete screening in a single appointment, while others require multiple visits over a few weeks.
Go Through Informed Consent
Before you officially enroll, the research team is legally required to walk you through informed consent. This isn’t just signing a form. It’s a conversation where you learn exactly what the trial involves, and you can ask questions at any point throughout the entire study, not just at the beginning.
Federal regulations require that the consent form cover eight specific areas: a description of what the study involves, foreseeable risks and benefits, alternative treatments available to you, how your privacy will be protected, who to contact with questions, and a clear statement that participation is voluntary. For trials involving more than minimal risk, the form must also explain what compensation or medical treatment is available if you’re injured during the study. An independent ethics board called an Institutional Review Board reviews and approves the consent form, the study design, and all materials before the trial can begin recruiting.
You’re never locked in. You can leave a trial at any time, for any reason, without it affecting your regular medical care.
What It Costs (and What You Might Be Paid)
Most clinical trials cover the cost of the experimental treatment and study-related tests. You generally won’t pay for the drug being tested or for lab work and imaging that’s part of the research protocol. However, your regular medical care costs, like doctor visits unrelated to the trial, may still go through your insurance as usual.
Compensation varies widely. International ethical guidelines distinguish between two types of payment: reimbursement for direct expenses like travel, parking, and lodging, and compensation for your time and inconvenience. Some trials pay nothing beyond covering your transportation. Others, particularly Phase I trials in healthy volunteers, may pay several hundred to several thousand dollars because the time commitment is significant. The consent form will spell out exactly what financial arrangement applies to your specific trial.
Questions Worth Asking Before You Commit
The screening process is also your chance to interview the research team. A few questions that will give you a clearer picture of what daily life in the trial looks like:
- How long will the trial last, and how often will I need to come in for visits?
- What side effects should I expect, and how do they compare to standard treatment?
- Is there a chance I’ll receive a placebo instead of the active treatment?
- If the treatment works for me, can I continue receiving it after the trial ends?
- Is long-term follow-up care included, and what does it involve?
- How long do I have to decide about joining?
There’s no pressure to answer on the spot. Reputable research teams expect you to take time, talk it over with family or your personal doctor, and come back with more questions. The goal of the process is to make sure you’re fully informed before you decide, not to rush you into a commitment.